Authors:
BALZARINI J
BROUWER WG
DAO DC
OSIKA EM
DECLERCQ E
Citation: J. Balzarini et al., IDENTIFICATION OF NOVEL THIOCARBOXANILIDE DERIVATIVES THAT SUPPRESS AVARIETY OF DRUG-RESISTANT MUTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 STRAINS AT A POTENCY SIMILAR TO THAT FOR WILD-TYPE VIRUS, Antimicrobial agents and chemotherapy, 40(6), 1996, pp. 1454-1466
Authors:
BALZARINI J
JONCKHEERE H
HARRISON WA
DAO DC
ANNE J
DECLERCQ E
KARLSSON A
Citation: J. Balzarini et al., OXATHIIN CARBOXANILIDE DERIVATIVES - A CLASS OF NONNUCLEOSIDE HIV-1-SPECIFIC REVERSE-TRANSCRIPTASE INHIBITORS (NNRTIS) THAT ARE ACTIVE AGAINST MUTANT HIV-1 STRAINS RESISTANT TO OTHER NNRTIS, Antiviral chemistry & chemotherapy, 6(3), 1995, pp. 169-178
Citation: Dc. Dao et G. Ferguson, (3AS(ASTERISK),9BS(ASTERISK))-(+ RO-2,9B-DIMETHYLTHIAZOLO[5,4-C]QUINOLIN-4(5H)-ONE/, Acta crystallographica. Section C, Crystal structure communications, 51, 1995, pp. 1823-1825
Authors:
BUCKHEIT RW
KINJERSKI TL
FLIAKASBOLTZ V
RUSSELL JD
STUP TL
PALLANSCH LA
BROUWER WG
DAO DC
HARRISON WA
SCHULTZ RJ
BADER JP
YANG SS
Citation: Rw. Buckheit et al., STRUCTURE-ACTIVITY AND CROSS-RESISTANCE EVALUATIONS OF A SERIES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-SPECIFIC COMPOUNDS RELATED TO OXATHIIN CARBOXANILIDE, Antimicrobial agents and chemotherapy, 39(12), 1995, pp. 2718-2727